EUCTR2012-001912-53-FI进行中（未招募）1 期
Inhaled salbutamol in elective caesarean section
Children's Hospital, Helsinki University Hospital0 个研究点目标入组 62 人开始时间: 2012年11月6日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 62
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •The study population consists of 62 healthy singleton newborn infants delivered by elective cesarean section at 37 + 0 to 41+6 gestational weeks.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 62
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) clinically significant congenital malformations, 2) birth weight < 2000 grams, 3) intubation, 4) heart rate > 200 bp for more than 5 min, 5) relevant medication of the mother, e.g. albetol, beta-agonists (e.g. salbutamol, salmeterol), corticosteroids and 6) the suspicion of/confirmed pneumothorax or infection
研究者
相似试验
Unknown
4 期
Inhaled Salbutamol in Elective Caesarean SectionPostnatal Pulmonary AdaptationCesarean SectionNCT01978418Sture Andersson62
招募中
不适用
Salbutamol delivered via Metered Dose Inhaler and Spacer versus Nebuliser to induce bronchodilatation during spirometryAsthmaACTRN12607000149460Respiratory Department, Box Hill Hospital40
招募中
4 期
Aerosolised salbutamol in two doses as a treatment for preterm infants with developing bronchopulmonary dysplasia.Chronic Lung Disease (CLD) and Bronchopulmonary Dysplasia (BPD)10028971NL-OMON33377Isala Klinieken10
进行中（未招募）
不适用
Aerosolised salbutamol in two doses as a treatment for preterm infants with developing bronchopulmonary dysplasia. - Salbutamol for developing BPDPreterm infants developing bronchopulmonary dysplasiaMedDRA version: 9.1Level: LLTClassification code 10006475Term: Bronchopulmonary dysplasiaEUCTR2009-010381-30-NLIsala klinieken
已完成
不适用
The effect of mode of inhaled salbutamol delivery on measures of small airways obstruction in asthma: a comparison of treatment delivered via spacer and nebuliserAsthmaACTRN12618001848291niversity of Otago14